QLY Biotech Group Corp.
QLY Biotech Group Corp. engages in the tourism business in the Dominican Republic. It organizes individual and group sailing tours. The company was formerly known as Azar International Corp. and changed its name to QLY Biotech Group Corp. in August 2022. QLY Biotech Group Corp. was incorporated in 2018 and is based in Las Vegas, Nevada.
QLY Biotech Group Corp. (LQLY) - Total Assets
Latest total assets as of February 2023: $0.00 USD
Based on the latest financial reports, QLY Biotech Group Corp. (LQLY) holds total assets worth $0.00 USD as of February 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
QLY Biotech Group Corp. - Total Assets Trend (2019–2022)
This chart illustrates how QLY Biotech Group Corp.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
QLY Biotech Group Corp. - Asset Composition Analysis
Current Asset Composition (August 2022)
QLY Biotech Group Corp.'s total assets of $0.00 consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2022)
This chart illustrates how QLY Biotech Group Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: QLY Biotech Group Corp.'s current assets represent 0.0% of total assets in 2022, a decrease from 100.0% in 2019.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, down from 100.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
QLY Biotech Group Corp. Competitors by Total Assets
Key competitors of QLY Biotech Group Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangzhou Dongfang Hotel Co Ltd
SHE:000524
|
China | CN¥3.85 Billion |
|
Hna-Caissa Travel Group Co Ltd
SHE:000796
|
China | CN¥1.93 Billion |
|
Emei Shan Tourism Co Ltd
SHE:000888
|
China | CN¥3.39 Billion |
|
Wuhan Sante Cableway Group Co Ltd
SHE:002159
|
China | CN¥1.88 Billion |
|
Parlo Bhd
KLSE:0022
|
Malaysia | RM25.61 Million |
|
Beijing Utour International Travel Service Co Ltd
SHE:002707
|
China | CN¥2.87 Billion |
|
Hana Tour
KO:039130
|
Korea | ₩740.11 Billion |
|
Sejoong Co. Ltd
KQ:039310
|
Korea | ₩117.45 Billion |
QLY Biotech Group Corp. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - QLY Biotech Group Corp. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - QLY Biotech Group Corp. is currently not profitable relative to its asset base.
QLY Biotech Group Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | - | - | |
| Quick Ratio | - | - | |
| Cash Ratio | - | - | |
| Working Capital | $- | - | - |
QLY Biotech Group Corp. - Advanced Valuation Insights
This section examines the relationship between QLY Biotech Group Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -100.0% |
| Total Assets | $0.00 |
| Market Capitalization | $894.99K USD |
Valuation Analysis
Below Book Valuation: The market values QLY Biotech Group Corp.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: QLY Biotech Group Corp.'s assets decreased by 100.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for QLY Biotech Group Corp. (2019–2022)
The table below shows the annual total assets of QLY Biotech Group Corp. from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-08-31 | $0.00 | -- |
| 2021-08-31 | $7.16K | -77.15% |
| 2020-08-31 | $31.34K | +526.74% |
| 2019-08-31 | $5.00K | -- |